ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 91 filers reported holding ENDOCYTE INC in Q3 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000,000 | +85614.3% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $7,000 | +133.3% | 2,250 | +125.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $5,000 | -16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $6,000 | -14.3% | 1,000 | 0.0% | 0.00% | -75.0% |
| Q2 2014 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |